Survival and Failure Outcomes in Primary Thyroid Lymphomas: A Single Centre Experience of Combined Modality Approach

Table 2

Treatment details.

Treatment approach
CCT + RT	14 (87.5%)
CCT alone	2 (12.5%)
CCT regimen
CHOP	15 (93.75%)
CVP	1 (6.25%)
RT
Dose (median)	36.0 Gy
Dose (range)	30–40 Gy